FIELD: medicine. SUBSTANCE: investigation has shown that claimed medicinal preparation having chemical formula possesses antiaggregate activity relative to thrombocytes. EFFECT: excellent means for prevention of thrombosis. 3 tbl
Title | Year | Author | Number |
---|---|---|---|
MATTER WITH ANTI-AGGREGATING ACTIVITY | 1993 |
|
RU2033158C1 |
NITROESTER OF OXIDIZED STARCH SODIUM SALT SHOWING ANTIAGGREGANT ACTION | 1991 |
|
RU2074195C1 |
2-CYCLOALKYLAMINO-5-THIENYL-1,3,4-THIADIAZINES, HYDROBROMIDES, WITH ANTIAGGREGANT ACTIVITY | 2008 |
|
RU2379306C1 |
METHOD FOR DETERMINING INDIVIDUAL SENSITIVITY TO NIFEDIPIN IN CARDIOVASCULAR PATIENTS | 0 |
|
SU1786437A1 |
16-METHYL-1,3,5(10)13-TETRAEN-D-HOMO-8-AZAGON-12, 17A- DION | 0 |
|
SU1039186A1 |
2-(1S,2R,5S)-6,6-DIMETHYLBICYCLO[3.1.1]HEPT-2YL]METHYL}THIONYL)ETHANOIC ACID, HAVING ANTIAGGREGANT ACTION | 2013 |
|
RU2522198C2 |
2-PIPERIDINO-5-(THIENYL-2)- AND 2-PIPERIDINO-5-(THIENYL-3)- 6H-1,3,4-THIADIAZINES HYDROBROMIDES POSSESSING ANTIAGGREGANT ACTION | 2010 |
|
RU2445310C2 |
1-SUBSTITUTED-3-{[2-(3,5-DI-TRET-4-HYDROXYPHENYL)-2-OXOETHYL]}-2AMINOBENZIMIDAZOLIUM BROMIDES WITH ANTIPLATELET AND ANTIOXIDANT PROPERTIES | 2016 |
|
RU2623439C1 |
METHOD FOR PATIENT-SPECIFIC SELECTION OF ANTIPLATELET DRUGS FOR PATIENTS IN NEED THEREOF | 2012 |
|
RU2499261C1 |
METHOD OF INDIVIDUAL PROGNOSIS OF CLINICAL EFFECTIVENESS OF DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME | 2016 |
|
RU2639772C1 |
Authors
Dates
1995-07-20—Published
1993-07-07—Filed